Health Care · Pharmaceutical Preparations · NYSE · CIK 200406 · FYE Jan 3 · Prices AT CLOSE 2026-08-20 (USD) Last $267.37 · Day −2.21% · Mkt cap $658.9B · P/E (FY) 24.8× · 1Y +53.2% · Off 52W high −3.3% · Vol (1Y) 18.9% Price2023-08-21 → 2026-08-20 JNJ close: $167 on 2023-08-21 to $267 on 2026-08-20. Split-adj closes · 240 of 6,695 · price returnⓘ At a glance | Short interest1.1% of sh out | | Days to cover3.0d | | 13F net flow (QoQ)+0.72% | | Top-10 13F concentration46.3% | | Next report (est.)2026-10-15 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)24.8× | | Sales (TTM)$97.93B | | Earnings (TTM)$21.04B | | Net margin28.5% | | EPS growth 3Y17.9% | | Sales growth 3Y5.6% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+30.6% | | 1Y+53.2% | | 3Y+74.4% | | 5Y+71.5% | | 10Y+193.1% | | Since incept. (ann.)+9.6% |
Total return · from 2000-01-03ⓘ Risk | Ann. volatility (1Y)18.9% | | Ann. volatility (3Y)17.9% | | Sharpe (1Y)2.42 | | Sharpe (3Y)1.13 | | Max drawdown (1Y)−11.0% | | Max drawdown (3Y)−14.4% | | Beta (3Y vs SPY)0.09 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 213.4M | $52.2B | 8.85% | +2.2% | | VANGUARD CAPITAL MANAGEMENT LLC | 156.6M | $38.3B | 6.50% | new | | STATE STREET CORP | 133.5M | $32.6B | 5.54% | −0.3% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 63.5M | $15.5B | 2.64% | new | | JPMORGAN CHASE & CO | 63.1M | $15.3B | 2.62% | +7.7% | | GEODE CAPITAL MANAGEMENT, LLC | 59.2M | $14.4B | 2.46% | +2.1% | | MORGAN STANLEY | 44.7M | $10.9B | 1.86% | −3.5% | | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 31.6M | $7.7B | 1.31% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-07-15 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-28 | 2026-07-15 | $2.27 | −0.9% | $25.31B | +6.6% | | 2026-03-29 | 2026-04-14 | $2.14 | −52.9% | $24.06B | +9.9% | | 2025-12-28 | 2026-01-21 | — | — | $24.56B | +9.1% | | 2025-09-28 | 2025-10-14 | $2.12 | +91.0% | $23.99B | +6.8% |
As-reported XBRL · next 2026-10-15 est.ⓘ Segment mixFY2025 (ended Dec 2025) Innovative Medicine 64% · Med Tech 36% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
